117 filings
Page 3 of 6
8-K
sx2sqmm1xt50p3hp9
9 May 22
AMWELL ANNOUNCES RESULTS FOR First QUARTER 2022
12:00am
DEFA14A
beshd338ewhb
29 Apr 22
Additional proxy soliciting materials
7:02am
8-K
fl5hgu3325ipllhsm
14 Apr 22
Departure of Directors or Certain Officers
5:01pm
424B7
cwn618he lh
31 Mar 22
Prospectus with selling stockholder info
4:45pm
8-K
drbbtara9b9 mo9q9as
7 Mar 22
Departure of Directors or Certain Officers
5:00pm
8-K
y3gfrh
24 Feb 22
Amwell® Announces Results for Fourth Quarter 2021 and Full Year 2021
4:17pm
8-K
dfhbbr
10 Nov 21
Amwell® Announces Results for Third Quarter 2021
4:11pm
S-3ASR
jgy0 2kbentgtcf6o
8 Oct 21
Automatic shelf registration
4:41pm
8-K
su73hp apvwy
21 Sep 21
Entry into a Material Definitive Agreement
5:00pm
D
l1lii0jr kasw6k64u8p
9 Sep 21
$60.1M in equity, sold $60.1M, 27 investors
12:54pm
8-K
22oce7et48lic1hk6 el
7 Sep 21
Departure of Directors or Certain Officers
5:00pm
D
sggvno
24 Aug 21
$55M in equity, sold $55M, 81 investors
4:30pm
8-K
1rdeypv4v31qs
11 Aug 21
Amwell® Announces Results for Second Quarter 2021
4:11pm
8-K
xzf s3h6efaql
28 Jul 21
Unregistered Sales of Equity Securities
5:28pm
8-K
ksikft99h d19um4d
23 Jul 21
Entry into a Material Definitive Agreement
5:00pm
8-K
05lkg 9nii
21 Jun 21
Departure of Directors or Certain Officers
4:31pm